Exscientia Plc's ability to collect accounts receivable sequentially worsen to 2.38, indicating more challenging environment then in the second quarter 2024, but still, it is a far cry from any concerns. Exscientia Plc's Accounts Receivable average collection period in the Sep 30 2024 quarter, has increased to 153 days, from 119 days, in the Jun 30 2024 quarter.

If we take a look into Healthcare sector 668 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2024 from 0 to 4535.

What is Receivable Turnover Ratio?
What is Exscientia Plc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

EXAI Receivables Turnover Ratio	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Dec 31 2023) IV. Quarter	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter
Y / Y Receivable Change	796.86 %	-65.04 %	580.3 %	6002.37 %	271.61 %
Y / Y Revenue Change	70.39 %	-20.35 %	-62.31 %	51.77 %	-58.07 %
Receivable Turnover Ratio (TTM)	2.38	3.07	3.2	4.35	29.35
EXAI's Total Ranking	# 4535	# 0	#	#	#
Accounts Receivable average collection period days	154	119	114	84	12
Seq. Receivable Change	5025.37 %	-93.12 %	-82.43 %	1347.07 %	99.79 %
Seq. Revenue Change	14.98 %	84.77 %	-73.17 %	198.91 %	-46.25 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 75
Healthcare Sector	# 669
Overall Market	# 4535

Receivable Turnover Ratio Statistics
High	Average	Low
0.04	0.04	0.04
(Dec 31 2022)		(Dec 31 2023)

EXAI Company Profile • Back to EXAI Efficiency Comparisons • Compare EXAI Receivables Turnover Ratio to its Competitors

Financial Statements
Exscientia Plc's Accounts Receivable	$ 15 Millions	Visit EXAI's Balance sheet
Exscientia Plc's Sales TTM	$ 26 Millions	Visit EXAI's Income Statement
Sources of EXAI's Revenues		Visit EXAI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
EXAI's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
EXAI's Growth Rates	EXAI's Roa	EXAI's Inventory Turnover Ratio	EXAI's Dividend Comparisons
EXAI's Profitability Ratios	EXAI's Roi	EXAI's Asset Turnover Ratio	EXAI's Dividend Growth
EXAI's Valuation Ratios	EXAI's Roe	EXAI's Financial Strength Ratios	EXAI's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2024, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2024	Receivable at quarter ending Sep 30 2024
Therapeutic Solutions International Inc	4.76	$ 0.085 Millions	$ 0.018 Millions
Dynavax Technologies Corporation	4.75	$ 260.811 Millions	$ 54.939 Millions
Scpharmaceuticals Inc	4.73	$ 30.278 Millions	$ 6.399 Millions
Organogenesis Holdings Inc	4.72	$ 455.038 Millions	$ 96.341 Millions
Cryo cell International Inc	4.72	$ 31.838 Millions	$ 6.752 Millions
Cue Biopharma Inc	4.71	$ 9.532 Millions	$ 2.024 Millions
Butterfly Network Inc	4.69	$ 75.171 Millions	$ 16.017 Millions
Regen Biopharma Inc	4.69	$ 0.237 Millions	$ 0.050 Millions
Xeris Biopharma Holdings Inc	4.68	$ 187.361 Millions	$ 40.047 Millions
Karyopharm Therapeutics Inc	4.65	$ 148.442 Millions	$ 31.954 Millions
Amgen Inc	4.60	$ 32,534.000 Millions	$ 7,073.750 Millions
Ligand Pharmaceuticals Incorporated	4.58	$ 152.618 Millions	$ 33.288 Millions
Intra cellular Therapies Inc	4.58	$ 613.728 Millions	$ 134.124 Millions
Quanterix Corporation	4.57	$ 134.312 Millions	$ 29.391 Millions
Bionano Genomics Inc	4.57	$ 33.334 Millions	$ 7.301 Millions
Sonoma Pharmaceuticals Inc	4.56	$ 13.547 Millions	$ 2.968 Millions
Pro dex Inc	4.56	$ 56.798 Millions	$ 12.453 Millions
Neuronetics Inc	4.56	$ 71.895 Millions	$ 15.764 Millions
Adaptive Biotechnologies Corporation	4.53	$ 177.282 Millions	$ 39.104 Millions
Lantheus Holdings Inc	4.52	$ 1,495.854 Millions	$ 330.826 Millions
Ironwood Pharmaceuticals inc	4.51	$ 378.418 Millions	$ 83.862 Millions
Kewaunee Scientific Corporation	4.51	$ 199.109 Millions	$ 44.144 Millions
Omniab Inc	4.47	$ 20.409 Millions	$ 4.565 Millions
Fennec Pharmaceuticals Inc	4.45	$ 49.348 Millions	$ 11.077 Millions
Organigram Global Inc	4.45	$ 122.438 Millions	$ 27.498 Millions
Emmaus Life Sciences Inc	4.45	$ 20.086 Millions	$ 4.513 Millions
Liquidia Corporation	4.43	$ 15.610 Millions	$ 3.521 Millions
Telesis Bio Inc	4.43	$ 12.190 Millions	$ 2.751 Millions
Vericel Corporation	4.43	$ 226.844 Millions	$ 51.191 Millions
Globus Medical Inc	4.43	$ 2,478.596 Millions	$ 559.350 Millions

Date modified: 2026-09-18T16:28:46+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.